Analysts' recommendations: Carmat SA

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris Other stock markets 2026-03-20			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Market Cap	6.15M 7.01M 5.67M 5.24M 9.94M 671M 10.14M 68.21M 26.5M 328M 26.31M 25.74M 1.14B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.55M 54.7M 50.54M 95.8M 6.47B 97.72M 658M 255M 3.17B 254M 248M 10.99B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
25-10-01	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Current year	0.1	0.1
1 year	0.08	0.59
3 years	0.08	9.99
5 years	0.08	31.7
10 years	0.08	44.95

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news : Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Course Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
25-03-12	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
25-03-12	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
24-05-28	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-77.24%	-98.66%	7.08M
STRYKER CORPORATION	-0.03%	+5.10%	-15.44%	+11.54%	126B
SMITH & NEPHEW PLC	-1.36%	+2.88%	+2.36%	-3.80%	12.87B
GLAUKOS CORPORATION	+1.84%	+11.52%	+49.78%	+116.85%	8.84B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.46%	-0.37%	-49.18%	-73.25%	3.87B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.81%	+3.71%	+20.09%	+40.77%	2.65B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-1.60%	-2.24%	-12.94%	-19.85%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-1.01%	+1.33%	-2.43%	-25.57%	1.61B
ENOVIS CORPORATION	-6.27%	+19.04%	-31.33%	-62.94%	1.47B
Average	-1.19%	+3.59%	-12.93%	-12.77%	17.73B
Weighted average by Cap.	-0.17%	+4.64%	-10.60%	+13.15%

	2023	2024
Net sales	3.84M 4.37M 3.54M 3.27M 6.2M 419M 6.33M 42.59M 16.55M 205M 16.43M 16.07M 712M	7.34M 8.37M 6.78M 6.27M 11.88M 802M 12.11M 81.51M 31.67M 392M 31.44M 30.75M 1.36B
Net income	-53.87M -61.42M -49.73M -45.96M -87.11M -5.88B -88.85M -598M -232M -2.88B -231M -226M -9.99B	-51.4M -58.6M -47.45M -43.85M -83.11M -5.61B -84.77M -570M -222M -2.75B -220M -215M -9.53B
Net Debt	49.64M 56.59M 45.83M 42.35M 80.26M 5.42B 81.87M 551M 214M 2.65B 213M 208M 9.21B	53.1M 60.54M 49.02M 45.3M 85.87M 5.8B 87.58M 589M 229M 2.84B 227M 222M 9.85B